Display options
Share it on

Iran J Pediatr. 2013 Feb;23(1):65-70.

Paucity of intrahepatic bile ducts in neonates: the first case series from iran.

Iranian journal of pediatrics

Zahmatkeshan Mozhgan, Geramizadeh Bita, Haghighat Mahmood, Enteshari Hajar

Affiliations

  1. Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 23550220 PMCID: PMC3574994

Abstract

OBJECTIVE: Paucity of interlobular bile ducts (PIBD), defined as absence or marked decrease in the number of interlobular bile ducts, is one of the causes of neonatal cholestasis. Treatment includes treating the intractable pruritus caused by persistent cholestasis. PIBD can be part of a familial syndrome of cholestasis named Alagille syndrome (AGS). We report clinical status of a case series of Iranian patients with PIBD.

METHODS: In this retrospective study, patients with cholestasis admitted to the pediatric gastroenterology ward in a referral hospital in Shiraz from January 2006 to January 2010 and underwent liver biopsy were evaluated. Clinical and paraclinical status of children with the pathologic diagnosis of PIBD was assessed.

FINDINGS: Disease was presented in all jaundiced patients with aged in average 3 days at presentation. Seven patients had the criteria of AGS. Despite medical treatment, cholestasis was not controlled in 6 (28.6%) patients. Liver transplantation led to the survival of 5 patients while the other patient who did not undergo liver transplantation died at 2 months of age. One patient underwent peritoneal dialysis due to renal insufficiency and died at 9 months of age. After 1-5 years of follow-up, the mortality rate was 9.5%.

CONCLUSION: In patients with intractable cholestasis, only patients that underwent liver transplantation survived. Thus, the most important criterion for liver transplantation in neonatal PIBD is intractable cholestasis. This is the first report that shows AGS can result in neonatal-onset renal insufficiency.

Keywords: Alagille Syndrome; Cholestasis; Neonates; Paucity of Interlobular Bile Ducts

References

  1. Am J Med Genet. 2002 Oct 1;112(2):163-70 - PubMed
  2. Semin Gastrointest Dis. 2003 Oct;14(4):156-64 - PubMed
  3. J Pediatr. 1975 Jan;86(1):63-71 - PubMed
  4. Can J Gastroenterol. 2007 Nov;21(11):743-51 - PubMed
  5. Gastroenterol Clin North Am. 2003 Sep;32(3):857-75, vi - PubMed
  6. J Pediatr. 1995 Aug;127(2):220-4 - PubMed
  7. Eur J Pediatr. 2011 Mar;170(3):279-84 - PubMed
  8. J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):84-9 - PubMed
  9. J Pediatr Gastroenterol Nutr. 2010 Jun;50(6):580-6 - PubMed
  10. Curr Gastroenterol Rep. 1999 Jun;1(3):223-30 - PubMed
  11. J Hepatobiliary Pancreat Surg. 2001;8(4):303-15 - PubMed
  12. J Pediatr Gastroenterol Nutr. 2002;35 Suppl 1:S17-23 - PubMed
  13. Nat Genet. 1997 Jul;16(3):235-42 - PubMed
  14. Clin Invest Med. 1996 Oct;19(5):325-30 - PubMed
  15. Curr Opin Pediatr. 1999 Dec;11(6):558-64 - PubMed
  16. Clin Liver Dis. 2000 Nov;4(4):765-78 - PubMed
  17. J Med Genet. 1997 Feb;34(2):152-7 - PubMed
  18. Hepatology. 1999 Mar;29(3):822-9 - PubMed
  19. Arch Dis Child. 1996 Mar;74(3):232-5 - PubMed
  20. Genomics. 1997 Aug 1;43(3):376-9 - PubMed
  21. Am J Med Genet A. 2004 Jan 15;124A(2):220-1; reply 222-3 - PubMed
  22. Adv Clin Path. 1998 Apr;2(2):87-99 - PubMed
  23. Curr Opin Genet Dev. 2002 Jun;12(3):336-42 - PubMed
  24. Pediatr Rev. 2004 Nov;25(11):388-96 - PubMed
  25. Gastroenterology. 2003 Oct;125(4):1227-34 - PubMed
  26. Neth J Med. 2010 Jan;68(1):38-9 - PubMed
  27. J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):11-5 - PubMed
  28. Curr Gastroenterol Rep. 2011 Apr;13(2):193-201 - PubMed

Publication Types